Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing

Signet ring cell carcinoma (SRCC) has specific oncogenesis and phenotypic and treatment resistance heterogeneity. Systemic therapies are often ineffective, and predictive biomarkers to guide treatment are urgently needed. Tumor organoids have recently emerged as an ideal model for drug testing and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guoliang, Ma, Shuai, Wu, Quanyou, Kong, Defeng, Yang, Zhenrong, Gu, Zhaoru, Feng, Lin, Zhang, Kaitai, Cheng, Shujun, Tian, Yantao, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748936/
https://www.ncbi.nlm.nih.gov/pubmed/35013129
http://dx.doi.org/10.1038/s41420-021-00803-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748936/
https://www.ncbi.nlm.nih.gov/pubmed/35013129
http://dx.doi.org/10.1038/s41420-021-00803-7

Ejemplares similares